Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/102008
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Stryjewski, Martin E. |
dc.contributor.author | Lentnek, Arnold |
dc.contributor.author | O'Riordan, William |
dc.contributor.author | Pullman, John |
dc.contributor.author | Tambyah, Paul Anantharajah |
dc.contributor.author | Miró Meda, José M. |
dc.contributor.author | Fowler, Vance G. |
dc.contributor.author | Barriere, Steven L. |
dc.contributor.author | Kitt, Michael M. |
dc.contributor.author | Corey, G.Ralph |
dc.date | 2016-09-21T07:30:45Z |
dc.date | 2016-09-21T07:30:45Z |
dc.date | 2014-05-23 |
dc.date | 2016-09-21T07:30:51Z |
dc.identifier.citation | 1471-2334 |
dc.identifier.citation | 649372 |
dc.identifier.uri | http://hdl.handle.net/2445/102008 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | BioMed Central |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/10.1186/1471-2334-14-289 |
dc.relation | Bmc Infectious Diseases, 2014, vol. 14, p. 289 |
dc.relation | http://dx.doi.org/10.1186/1471-2334-14-289 |
dc.rights | cc-by (c) Stryjewski, M.E. et al., 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Staphylococcus aureus |
dc.subject | Antibiòtics |
dc.subject | Contaminació microbiana |
dc.subject | Estudi de casos |
dc.subject | Infeccions nosocomials |
dc.subject | Staphylococcus aureus |
dc.subject | Antibiotics |
dc.subject | Microbial contamination |
dc.subject | Case studies |
dc.subject | Nosocomial infections |
dc.title | A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study. |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |